Abstract
The purpose of this study was to evaluate the efficacy and tolerability of the addition of 2 monoclonal antibodies, bevacizumab and cetuximab, to 2 cycles of high-dose cisplatin administered concurrently with intensity-modulated radiation therapy (IMRT) for head and neck squamous cell carcinoma (HNSCC). Patients with newly diagnosed stage III/IVB (M0) HNSCC received cetuximab (400 mg/m(2) loading dose, followed by 250 mg/m(2) weekly), bevacizumab (15 mg/kg, days 1 and 22), and cisplatin (50 mg/m(2) , days 1, 2, 22, and 23) concurrently with IMRT (70 Gy). The primary endpoint was progression-free survival (PFS). Secondary endpoints were overall survival (OS) and safety and tolerability. Among 30 patients enrolled in this study, the primary tumor site was the oropharynx in 24 patients (p16 immunohistochemistry was positive in 17, negative in 1, and not done in 6 of the oropharyngeal tumors). Median age was 57 years (range, 38-77 years) and 27 patients had clinical stage IVA disease. All patients completed the full planned dose of radiation therapy. The most common ≥ grade 3 adverse events were lymphopenia, mucositis (functional), and dysphagia. With a median follow-up of 33.8 months, 2-year PFS was 88.5% (95% confidence interval ...Continue Reading
References
Aug 1, 1990·Cancer·M A ListS B Lansky
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David J AdelsteinArlene A Forastiere
Dec 3, 2003·The New England Journal of Medicine·Arlene A ForastiereJay Cooper
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Panayiotis A KyzasJohn P A Ioannidis
Feb 10, 2006·The New England Journal of Medicine·James A BonnerK Kian Ang
May 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xudong TangAnh D Le
Sep 12, 2008·The New England Journal of Medicine·Jan B VermorkenRicardo Hitt
Feb 10, 2009·The Lancet Oncology·Ezra E W CohenEverett E Vokes
Nov 10, 2009·The Lancet Oncology·James A BonnerK Kian Ang
Jun 10, 2010·The New England Journal of Medicine·K Kian AngMaura L Gillison
Feb 19, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J K SalamaE E Vokes
Sep 29, 2011·The Cancer Journal·John D HainsworthAnthony Meluch
Jan 19, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David S YooDavid M Brizel
Mar 15, 2012·Cancer·Matthew G FuryDavid G Pfister
Aug 18, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A ArgirisS Kim
Jun 28, 2013·Head & Neck·Yao-Tiao DengYu Jiang
Feb 21, 2014·The New England Journal of Medicine·Krishnansu S TewariBradley J Monk
Aug 27, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Kian AngRita S Axelrod
Citations
Sep 24, 2015·Oncology Reports·Enjiao ZhangLi Lu
Nov 26, 2015·Advanced Drug Delivery Reviews·Daniel R Wahl, Theodore S Lawrence
Oct 16, 2015·BMC Cancer·James A BonnerEddy S Yang
Nov 9, 2015·Cancer Treatment Reviews·Linda M HenricksJos H Beijnen
Jul 12, 2016·Current Oral Health Reports·Rebecca C Hoesli, Jeffrey S Moyer
May 15, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A ArgirisR L Ferris
Feb 29, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Shih-Hsin ChenTzu-Chen Yen
Jun 2, 2016·Critical Reviews in Oncology/hematology·Kelly K CurtisHelen J Ross
Sep 21, 2016·Cancer·Nicole G Chau, Robert I Haddad
Apr 17, 2019·Cancers·Jens von der GrünPanagiotis Balermpas
Nov 25, 2016·Head & Neck·Samuel Lamarre SkulskyJames Paul O'Neill
Mar 20, 2018·Cancer Growth and Metastasis·Kimberly M ArnoldJennifer Sims-Mourtada
Apr 14, 2020·Cancers of the Head & Neck·Ida MicailyAthanassios Argiris
Jan 18, 2017·Cancers of the Head & Neck·Paolo Bossi, Francesca Platini
Jun 6, 2019·Frontiers in Oncology·Miren TabernaRicard Mesía
Jan 16, 2021·Biomolecules·Sven NiklanderMarcela Hernández
Sep 25, 2019·Surgical Oncology·Lian LiuJunhui Huang
Mar 16, 2021·Frontiers in Oncology·Sandra Ortiz-CuaranPierre Saintigny
Jul 2, 2021·Frontiers in Oncology·Aini HyytiäinenAhmed Al-Samadi
Jun 13, 2021·Head & Neck·Cristiana BergaminiLisa Licitra